141 related articles for article (PubMed ID: 10374838)
1. Growth inhibition of neuroblastoma cells by lovastatin and L-ascorbic acid is based on different mechanisms.
Girgert R; Vogt Y; Becke D; Bruchelt G; Schweizer P
Cancer Lett; 1999 Apr; 137(2):167-72. PubMed ID: 10374838
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.
Rao S; Porter DC; Chen X; Herliczek T; Lowe M; Keyomarsi K
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7797-802. PubMed ID: 10393901
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.
Hedl M; Rodwell VW
Protein Sci; 2004 Jun; 13(6):1693-7. PubMed ID: 15152097
[TBL] [Abstract][Full Text] [Related]
5. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.
Wang W; Macaulay RJ
Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the response of growth and differentiation to lipoproteins and agents affecting cholesterol metabolism in murine neuroblastoma cells.
Castellano F; Bruscalupi G; Columba S; Di Croce L; Trentalance A; Augusti-Tocco G
Int J Dev Neurosci; 1994 Feb; 12(1):77-84. PubMed ID: 8010162
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of farnesylation blocks growth but not differentiation in FRTL-5 thyroid cells.
Bifulco M; Laezza C; Aloj SM
Biochimie; 1999 Apr; 81(4):287-90. PubMed ID: 10401660
[TBL] [Abstract][Full Text] [Related]
8. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates.
Cuthbert JA; Lipsky PE
J Biol Chem; 1991 Sep; 266(27):17966-71. PubMed ID: 1917936
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase.
Johnson MD; Woodard A; Okediji EJ; Toms SA; Allen GS
J Neurooncol; 2002 Jan; 56(2):133-42. PubMed ID: 11995814
[TBL] [Abstract][Full Text] [Related]
12. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells.
Dimitroulakos J; Yeger H
Nat Med; 1996 Mar; 2(3):326-33. PubMed ID: 8612233
[TBL] [Abstract][Full Text] [Related]
14. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
[TBL] [Abstract][Full Text] [Related]
15. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ
Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100
[TBL] [Abstract][Full Text] [Related]
16. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
17. Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes.
Elfakhani M; Torabi S; Hussein D; Mills N; Verbeck GF; Mo H
Exp Biol Med (Maywood); 2014 Mar; 239(3):293-301. PubMed ID: 24477821
[TBL] [Abstract][Full Text] [Related]
18. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture.
Sindermann JR; Fan L; Weigel KA; Troyer D; Müller JG; Schmidt A; March KL; Breithardt G
Atherosclerosis; 2000 Jun; 150(2):331-41. PubMed ID: 10856525
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
